IRIS
MORINI, Giovanni
 Distribuzione geografica
Salva come PNG Salva come JPEG
Continente #
NA - Nord America 2.135
AS - Asia 1.737
EU - Europa 1.391
SA - Sud America 220
AF - Africa 103
Continente sconosciuto - Info sul continente non disponibili 9
OC - Oceania 3
Totale 5.598
Salva come PNG Salva come JPEG
Nazione #
US - Stati Uniti d'America 2.065
SG - Singapore 612
CN - Cina 508
FI - Finlandia 349
VN - Vietnam 266
SE - Svezia 250
IE - Irlanda 205
DE - Germania 185
BR - Brasile 165
UA - Ucraina 140
HK - Hong Kong 109
BD - Bangladesh 75
TR - Turchia 62
ZA - Sudafrica 61
FR - Francia 50
GB - Regno Unito 49
CA - Canada 45
NL - Olanda 44
IT - Italia 41
CI - Costa d'Avorio 24
AR - Argentina 21
BE - Belgio 20
IN - India 20
MX - Messico 18
ES - Italia 17
PH - Filippine 12
JP - Giappone 11
RU - Federazione Russa 11
PL - Polonia 10
EC - Ecuador 9
PK - Pakistan 9
IQ - Iraq 7
UZ - Uzbekistan 7
MA - Marocco 6
AT - Austria 5
CO - Colombia 5
CZ - Repubblica Ceca 5
ID - Indonesia 5
TH - Thailandia 5
VE - Venezuela 5
BO - Bolivia 4
EG - Egitto 4
JO - Giordania 4
CL - Cile 3
IR - Iran 3
JM - Giamaica 3
LB - Libano 3
LT - Lituania 3
PE - Perù 3
PY - Paraguay 3
TW - Taiwan 3
AU - Australia 2
AZ - Azerbaigian 2
DZ - Algeria 2
EE - Estonia 2
KR - Corea 2
KZ - Kazakistan 2
OM - Oman 2
SA - Arabia Saudita 2
AE - Emirati Arabi Uniti 1
AL - Albania 1
AM - Armenia 1
AO - Angola 1
BB - Barbados 1
BW - Botswana 1
BY - Bielorussia 1
CR - Costa Rica 1
DO - Repubblica Dominicana 1
ET - Etiopia 1
GA - Gabon 1
GE - Georgia 1
GR - Grecia 1
GY - Guiana 1
KH - Cambogia 1
LY - Libia 1
MY - Malesia 1
PA - Panama 1
RO - Romania 1
RS - Serbia 1
SY - Repubblica araba siriana 1
TN - Tunisia 1
TV - Tuvalu 1
UY - Uruguay 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 5.590
Salva come PNG Salva come JPEG
Città #
Singapore 319
Ashburn 236
Chandler 222
Dublin 205
Jacksonville 189
San Jose 170
Santa Clara 125
Beijing 115
Ann Arbor 108
Hong Kong 102
Dearborn 87
Ho Chi Minh City 83
New York 75
Boardman 59
Nanjing 59
Council Bluffs 58
Johannesburg 57
Izmir 54
Dallas 53
Hanoi 52
Los Angeles 50
Munich 42
Shanghai 42
Princeton 37
Toronto 31
Lauterbourg 30
San Mateo 29
Abidjan 24
Buffalo 21
Helsinki 21
Jinan 21
Brussels 20
Hebei 19
Wilmington 19
Bremen 18
Hefei 17
Nanchang 17
Turku 17
Des Moines 15
Frankfurt am Main 15
São Paulo 15
Shenyang 14
Haiphong 13
Grafing 12
Tianjin 12
Guangzhou 11
Houston 11
Kunming 11
Tokyo 11
Changsha 10
Columbus 10
Da Nang 10
London 9
Phoenix 9
Seattle 9
Belo Horizonte 7
Falkenstein 7
Mexico City 7
Montreal 7
Orem 7
Woodbridge 7
Can Tho 6
Haikou 6
Hangzhou 6
Jiaxing 6
Warsaw 6
Amsterdam 5
Atlanta 5
Bắc Ninh 5
Chennai 5
Denver 5
Milan 5
Moscow 5
Norwalk 5
Quito 5
Rio de Janeiro 5
Tashkent 5
Amman 4
Bexley 4
Biên Hòa 4
Boston 4
Brooklyn 4
Charlotte 4
Dhaka 4
Guarulhos 4
Lahore 4
Poplar 4
Queens 4
Redondo Beach 4
Ribeirão das Neves 4
Stockholm 4
Taiyuan 4
Tây Ninh 4
Vienna 4
Wroclaw 4
Wuhan 4
Zhengzhou 4
Auburn Hills 3
Augusta 3
Brasília 3
Totale 3.316
Salva come PNG Salva come JPEG
Nome #
Effect of Cl-Substitution on Rooting- or Cytokinin-like Activity of Diphenylurea Derivatives 220
A promising imidazole-free histamine H3 receptor antagonist with good brain penetration and anticholinesterase activity. 220
Azionifarmacologiche di composti alchilaminoalchilfenilbenzisotiazolici sul trattogastrointestinale 196
The Role of HB-Donor Groups in the Heterocyclic Polar Fragment of H3-Antagonists. I. Synthesis and Biological Assays 185
Validation of a histamine H3 receptor model through structure–activity relationships for classical H3 antagonists 182
4-(1,2-benzisothiazol-3-)alkanoic and phenylalkanoic acids: synthesis and anti-inflammatory, analgesic and antipyretic activities 178
Action of histamine and ofdifferent synthetic P^ receptor stimulants on the isolated gastric fundus of theguinea pig 176
4-(3-Oxo-1,2-benzisothiazolin-2-yl)alkanoic, phenyl and phenoxyalkanoic acids: synthesis and anti-inflammatory, analgesic, and antipyretic properties 175
Dual-Acting Drugs: an in vitro Study of Nonimidazole Histamine H(3) Receptor Antagonists Combining Anticholinesterase Activity 168
The anti-H1-histaminic and antimuscarinic effect of 2- and 4-[benzyl-(2-dimethylaminoethyl)amino]pyrimidine compounds]. 168
Dibasic non-imidazole histamine H3 receptor antagonists with a rigid byphenyl scaffold. 165
Antiulcer long-term treatment in chronic ulcer rat 160
H3-antagonists: synthesis and activity of 2-amino-5-thiazolyl derivatives 156
Cytokinin-like activity of N,N'-diphenylureas. N,N'-bis-(2,3-methylenedioxyphenyl)urea and N,N'-bis-(3,4-methylenedioxyphenyl)urea enhance adventitious root formation in apple rootstock M26 (Malus pumila Mill) 153
Synthesis and 3D-QSAR Analysis of H3 Receptor Antagonists Containing a Neutral Heterocyclic Polar Group 151
Biological studies on 1,2-benzisothiazole derivatives. V. Antimicrobial properties of N-alkanoic, N-arylalkanoic and N-aryloxyalkanoic derivatives of 1,2-benzisothiazolin-3-one: QSAR study and genotoxicity evaluation 150
In vitro and in vivo pharmacological analysis of imidazole-free histamine H3 receptor antagonists: promising results for a brain-penetrating H3 blocker with weak anticholinesterase activity. 143
Synthesis and biological evaluation of new non-imidazole H(3)-receptor antagonists of the 2-aminobenzimidazole series 143
A possible physiological role ofhistamine H^-receptors in rat mesenteric circulation 141
Hz-agonistiimidazolici: importanza della 2-amino sostituzione per 1'attivita farmacologica 141
Discovery of histamine H3 receptor antagonistic property of simple imidazole-free derivatives: preliminary pharmacological investigation. 140
Synthesis and biological assays of new H3-antagonists with imidazole and imidazoline polar groups 139
Diheteroarylurea derivatives as adventitious rooting adjuvants in mung bean shoots and M26 apple rootstock. 136
HPLC detection ofthioperamide from biological samples and its determination in rat blood and brainafter systemic administration 136
Heteroarylaminoethyl and heteroarylthioethylimidazoles. Synthesis and H3-receptor affinity 135
Histamine H3-antagonists: the basicity of the polar group in quantitative structure-activity and structure-property relationship 134
Synthesis and structure-activity relationships for biphenyl H3 receptor antagonists with moderate anti-cholinesterase activity. 130
Pharmacological activities of two new histamine analogs 116
Synthesis of benzisoxazole and benzisothiazole derivatives with potential antitumor activity 115
Influence of urea-equivalent groups in position 5 of 2-amino, 2-(1-aminoethylidenamino) and 2-guanidino thiazole derivatives on H3-receptor antagonist activity in gastric fistula cat 114
Multi-target-directed ligands: new histamine H3 receptor antagonists with anticholinesterase activity 110
Liquid chromatography-mass spectrometric method for determination of the non-imidazole H(3) -receptor antagonist UPR1056 in rat plasma. 110
In vitro pharmacology at human histamine H(3) receptors and brain access of non-imidazole alkylpiperidine derivatives. 109
Antipyreticactivity of new compounds 4-(3-oxo-l,2-benzisothiazolin-2-yl)puenyialkanoicacids, their esters, amides and 1,1 dioxide derivatives 107
Studio di sostanze analoghe alDimaprit sulla secrezione gastrica "in vitro" 103
Rat protein binding and cerebral phospholipid affinity of the H3-receptor antagonist thioperamide 102
Synthesis and binding assays of H3-receptor ligands. 100
Are histamine receptors involved in the stimulant activities ofthiazolylethylamines supposed as cyclic models of dimaprit? 93
null 61
null 37
Totale 5.598
Salva come PNG Salva come JPEG
Categoria #
all - tutte 18.766
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 18.766
Salva come PNG Salva come JPEG


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022201 0 1 4 19 12 16 26 28 10 12 14 59
2022/2023815 100 98 59 53 79 92 17 45 241 5 20 6
2023/2024264 16 27 4 7 17 92 25 11 10 9 15 31
2024/2025887 36 44 55 58 78 118 16 43 102 81 76 180
2025/20261.984 172 162 165 197 294 126 189 79 331 135 58 76
2026/202796 37 59 0 0 0 0 0 0 0 0 0 0
Totale 5.598